Literature DB >> 7859584

Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis.

J W Freston1, K Borch, S J Brand, E Carlsson, W Creutzfeldt, R Håkanson, L Olbe, E Solcia, J H Walsh, M M Wolfe.   

Abstract

Since hypochlorhydria can induce hypergastrinemia, and gastrin has a trophic effect on some gastrointestinal cells, states that cause elevated plasma gastrin levels are of interest in terms of effects on cell growth and function. This article reviews the relationship between gastric mucosal cells during periods of acid stimulation and inhibition and analyses the effects of hypochlorhydria and hypergastrinemia on gastric and colonic cells and tumors. Hypochlorhydria releases the inhibitory effect of antral gastrin cells, inducing them to release gastrin in the presence of peptides or amino acids in the gastric lumen or in response to antral distension. Gastrin stimulates the oxyntic mucosa, which may lead to hyperplasia of enterochromaffin-like cells, resulting in enterochromaffin-like carcinoid tumors in aged rats and, rarely, in patients with chronic atrophic gastritis or gastrinomas. In addition to hypergastrinemia, other factors appear to be required for the progression of enterochromaffin-like hyperplasia to carcinoids; genetic factors may be involved. Gastrin elevations due to antisecretory drug therapy are indirectly proportional to the degree of acid inhibition and are reversible upon cessation of therapy. The gastrin levels during omeprazole therapy are similar to those caused by gastric vagotomy. Available evidence does not support a relationship between hypergastrinemia and the occurrence or growth of gastric carcinoma or colonic tumors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859584     DOI: 10.1007/bf02214871

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  139 in total

1.  Elevated gastrin levels in patients with colon cancer or adenomatous polyps.

Authors:  J P Smith; J G Wood; T E Solomon
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

2.  Atrophic gastritis and gastric carcinoid tumours.

Authors:  K Borch
Journal:  Ann Med       Date:  1989-08       Impact factor: 4.709

Review 3.  Role of gastrin and cholecystokinin in tumours of the gastrointestinal tract.

Authors:  C B Lamers; J B Jansen
Journal:  Eur J Cancer Clin Oncol       Date:  1988-02

4.  Effect of gastro-entero-pancreatic endocrine hormones on the histogenesis of gastric cancer in rats induced by N-methyl-N'-nitro-N-nitrosoguanidine; with special reference to development of scirrhous gastric cancer.

Authors:  E Tahara; S Haizuka
Journal:  Gan       Date:  1975-08

5.  Prolonged inhibition of acid secretion causes hypergastrinaemia without altering pH inhibition of gastrin release in humans.

Authors:  W E Karnes; R G Berlin; V Maxwell; B Sytnik; J K Root; J H Walsh
Journal:  Aliment Pharmacol Ther       Date:  1990-10       Impact factor: 8.171

6.  Mitogenic response of canine fundic epithelial cells in short-term culture to transforming growth factor alpha and insulinlike growth factor I.

Authors:  M C Chen; A T Lee; A H Soll
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

7.  Effect of prolonged administration of gastrin on experimental carcinogenesis in rat colon induced by intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  M Tatsuta; H Yamamura; M Ichii; H Taniguchi
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

8.  Interactions between antral peptides and prostaglandin biosynthesis in gastric acid regulation in man.

Authors:  R Befrits; K Uvnäs-Moberg; C Johansson
Journal:  Digestion       Date:  1990       Impact factor: 3.216

9.  Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies.

Authors:  R Håkanson; G Böttcher; E Ekblad; P Panula; M Simonsson; M Dohlsten; T Hallberg; F Sundler
Journal:  Histochemistry       Date:  1986

10.  Effect of prolonged administration of gastrin on experimental carcinogenesis in rat stomach induced by N-methyl-N' -nitro-N-nitrosoguanidine.

Authors:  M Tatsuta; T Itoh; S Okuda; H Taniguchi; H Tamura
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

View more
  8 in total

Review 1.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

2.  Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.

Authors:  Tan Attila; Raj Santharam; Dennis Blom; Richard Komorowski; Timothy R Koch
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

3.  Long-term proton pump inhibitor use in children: a retrospective review of safety.

Authors:  V Tolia; K Boyer
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

4.  Long term omeprazole therapy for reflux esophagitis:follow-up in serum gastrin levels,EC cell hyperplasia and neoplasia.

Authors:  Pankaj Singh; Anant Indaram; Ronald Greenberg; Vernu Visvalingam; Simmy Bank
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 5.  Safety profile of Lansoprazole: the US clinical trial experience.

Authors:  J W Freston; P A Rose; C A Heller; M Haber; D Jennings
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 6.  Chemoprevention of colorectal cancer.

Authors:  M Langman; P Boyle
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

7.  Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment.

Authors:  Benjamin D Gold; James W Freston
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 8.  Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders.

Authors:  P Richardson; C J Hawkey; W A Stack
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.